Earnings Call · Q3 FY2024·2024-11-06

Q3 24EPS +12.86%·Rev n/aQ2 24EPS +27.14%·Rev n/aQ1 24EPS 0.00%·Rev n/aQ4 23EPS +2.30%·Rev n/a⚠ consensus missing

Pacira BioSciences, Inc. PCRX

Susan Mesco — Head of Investor Relations

Frank Lee — Chief Executive Officer

Shawn Cross — Chief Financial Officer

+0.2%1d on move date−0.6% vs SPY3d−1.0%5d−6.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCRX calls or request research access.

More PCRX calls Browse calls Request research access